- Home
- FATE vs ISPR Comparison
FATE vs ISPR Comparison
Compare FATE & ISPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FATE | ISPR |
|---|---|---|
| Founded | 2007 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 125.6M | 103.9M |
| IPO Year | 2013 | 2023 |
Fundamental Metrics
Financial Performance| Metric | FATE | ISPR |
|---|---|---|
| Price | $2.01 | $1.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $4.10 | ★ $7.50 |
| AVG Volume (30 Days) | ★ 4.5M | 126.5K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.88 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $6,646,000.00 | ★ $127,494,304.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $14.31 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.91 | $1.19 |
| 52 Week High | $2.88 | $3.87 |
Technical Indicators
Market Signals| Indicator | FATE | ISPR |
|---|---|---|
| Relative Strength Index (RSI) | 47.30 | 47.04 |
| Support Level | $1.00 | $1.54 |
| Resistance Level | $2.88 | $1.98 |
| Average True Range (ATR) | 0.26 | 0.24 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 30.62 | 23.00 |
Price Performance
Historical ComparisonAbout FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
About ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping products in the United States, Europe, Canada, and South Africa. Geographically, the company generates the majority of its revenue from Europe.